Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AVIENT CORP Director's Dealing 2024

May 14, 2024

31389_dirs_2024-05-14_a38f45be-7f63-4e02-8ae3-a23497c91168.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AVIENT CORP (AVNT)
CIK: 0001122976
Period of Report: 2024-05-10

Reporting Person: Garratt Michael A (SVP, President CAI - EMEA)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-05-10 Common Stock M 11050 $41.89 Acquired 40224 Direct
2024-05-10 Common Stock F 10420 $45.49 Disposed 29804 Direct
2024-05-10 Common Stock M 9200 $38.27 Acquired 39004 Direct
2024-05-10 Common Stock F 8147 $45.49 Disposed 30857 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-05-10 Stock Appreciation Rights $41.89 M 11050 Disposed 2028-02-14 Common Stock (11050) Direct
2024-05-10 Stock Appreciation Rights $38.27 M 9200 Disposed 2025-02-04 Common Stock (9200) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 15134.001 Indirect

Footnotes

F1: The information in this report is based on a plan statement as of May 10, 2024.

F2: SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $41.89 per share and no more than one-third of the grant can vest per year during the first three years.

F3: SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $38.27 per share and no more than one-third of the grant can vest per year during the first three years.